Not a trace will be left: implants with unique properties developed at NUST MISIS

NUST MISIS and Osteo-Syber have created the country's first line of resorbable medical structures

Scientists from NUST MISIS, together with the company "Osteo-Syber", have developed and launched the production of bioresorbable magnesium implants for maxillofacial surgery and traumatology. These structures do not require removal, as they gradually dissolve in the body, being replaced by bone tissue.

The development includes 18 types of products for traumatology and 6 for maxillofacial surgery — screws, pins and plates. The uniqueness of the alloys lies in the controlled rate of resorption and high biocompatibility, which reduces rehabilitation and reduces the risk of complications.

The first operations with the new implants were performed at the Russian University of Medicine. According to Alexander Komissarov, Director of the Advanced Engineering School of NUST MISIS, the results confirmed the effectiveness and safety of the technology.

The first proactive clinical testing took place at the Russian University of Medicine of the Ministry of Health of Russia. Colleagues confirmed the prospects of the developed approach. We performed two operations – the implants showed a high degree of fixation, resorption passed without complications. This is a significant achievement not only for the research team of NUST MISIS, but also a weighty argument in favor of moving to a new level of maxillofacial surgery. Now, together with an industrial partner, we are in the process of obtaining a registration certificate from Roszdravnadzor.
Alexander Komissarov, Director of the Advanced Engineering School of NUST MISIS

The company "Osteo-Syber", a resident of Skolkovo, is already negotiating supplies to India, the Middle East and Latin America.

We have passed a key scientific stage and are entering the market with a ready-made product, which is already generating interest in India, the Middle East and Latin America. Thanks to the partnership with MISIS and leading medical institutions, we have created a full-cycle technology and are ready to scale. The market potential is huge – and we know how to realize it.
Margarita Kellerman, Head of Osteo-Syber

The project is implemented within the framework of the Priority 2030 program and corresponds to the strategy of the Ministry of Industry and Trade to localize critically important products.

Read more materials on the topic:

Vessels in the light: an innovative method for examining the human body has been developed

New hope: terahertz radiation can help in the fight against oncology

A new method for synthesizing complex molecules in one step: a breakthrough in the development of drugs and materials